↓ Skip to main content

Opioids for agitation in dementia

Overview of attention for article published in Cochrane database of systematic reviews, May 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

news
1 news outlet
twitter
15 tweeters

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
255 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Opioids for agitation in dementia
Published in
Cochrane database of systematic reviews, May 2015
DOI 10.1002/14651858.cd009705.pub2
Pubmed ID
Authors

Richard Brown, Robert Howard, Bridget Candy, Elizabeth L Sampson

Abstract

Agitation is a common experience for people living with dementia, particularly as day-to-day function and cognition start to decline more. At the present time there are limited pharmacological options for relieving agitation and little is known about the safety and efficacy of opioid drugs in this setting. To determine the clinical efficacy and safety of opioids for agitation in people with dementia. We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group Specialized Register, on 13 June 2014 using the terms: narcotic OR opioid OR opium OR morphine OR buprenorphine OR codeine OR dextromoramide OR diphenoxylate OR dipipanone OR dextropropoxyphene OR propoxyphene OR diamorphine OR dihydrocodeine OR alfentanil OR fentanyl OR remifentanil OR meptazinol OR methadone OR nalbuphine OR oxycodone OR papaveretum OR pentazocine OR meperidine OR pethidine OR phenazocine OR hydrocodone OR hydromorphone OR levorphanol OR oxymorphone OR butorphanol OR dezocine OR sufentanil OR ketobemidone.ALOIS contains records of clinical trials identified from monthly searches of a number of major healthcare databases such as MEDLINE, EMBASE and PscyINFO, as well as numerous trial registries and grey literature sources. Randomised, controlled trials of opioids compared to placebo for agitation in people with dementia. Two authors independently assessed the studies identified by the search against the inclusion criteria. There are currently no completed randomised, placebo controlled trials of opioids for agitation in dementia. There are two potentially relevant trials still in progress. We found insufficient evidence to establish the clinical efficacy and safety of opioids for agitation in people with dementia. There remains a lack of data to determine if or when opioids either relieve or exacerbate agitation. More evidence is needed to guide the effective, appropriate and safe use of opioids in dementia.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 255 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 255 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 33 13%
Student > Bachelor 31 12%
Researcher 30 12%
Student > Ph. D. Student 27 11%
Student > Doctoral Student 16 6%
Other 49 19%
Unknown 69 27%
Readers by discipline Count As %
Medicine and Dentistry 79 31%
Nursing and Health Professions 33 13%
Psychology 18 7%
Social Sciences 10 4%
Agricultural and Biological Sciences 7 3%
Other 31 12%
Unknown 77 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2020.
All research outputs
#1,350,170
of 19,579,367 outputs
Outputs from Cochrane database of systematic reviews
#3,309
of 11,961 outputs
Outputs of similar age
#20,596
of 242,111 outputs
Outputs of similar age from Cochrane database of systematic reviews
#84
of 242 outputs
Altmetric has tracked 19,579,367 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,961 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.6. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,111 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 242 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.